Literature DB >> 19173306

Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation.

Athanasios Papakyriakou1, Dionisios Vourloumis, Fotini Tzortzatou-Stathopoulou, Michael Karpusas.   

Abstract

The epidermal growth factor receptor (EGFR) has been the focus of intensive studies because of its importance in cancer research. Thus, a broader understanding of the molecular mechanism of activation of the EGFR kinase will have profound significance for the development of novel therapeutics. Numerous crystal structures of EGFR kinase, including the structure of the activating-kinase dimer, have provided snapshots of the specific pathway. Herein, we performed unrestrained-, as well as targeted-molecular dynamics simulations based on these data, to gain further insight into the conformational changes responsible for activation. Comparison of the monomer- versus activating-EGFR-dimer simulations indicates that the dimerization is stabilizing structural elements associated with the activated state and predicts new salt-bridge interactions involving activation-loop residues that may also be associated with that state. Targeted molecular dynamics simulations of the inactive-to-active EGFR transition, as well as the reverse pathway, confirm the formation of conserved structural features of functional importance for the activity or stabilization of either conformation. Interestingly, simulations of the L834R mutant, which is associated with cancer, suggest that the structural basis of the activation induced by that mutation might be the ability of the mutated R834 residue to consecutively form salt bridges with neighboring acidic residues and cause destabilization of a hydrophobic cluster in the inactive state. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19173306     DOI: 10.1002/prot.22353

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  15 in total

1.  Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.

Authors:  Andrew J Shih; Shannon E Telesco; Sung-Hee Choi; Mark A Lemmon; Ravi Radhakrishnan
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

2.  Exploring the dynamics and interaction of a full ErbB2 receptor and Trastuzumab-Fab antibody in a lipid bilayer model using Martini coarse-grained force field.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martinez-Salazar
Journal:  J Comput Aided Mol Des       Date:  2014-08-17       Impact factor: 3.686

3.  Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.

Authors:  Katharine A White; Diego Garrido Ruiz; Zachary A Szpiech; Nicolas B Strauli; Ryan D Hernandez; Matthew P Jacobson; Diane L Barber
Journal:  Sci Signal       Date:  2017-09-05       Impact factor: 8.192

4.  Molecular modeling of ErbB4/HER4 kinase in the context of the HER4 signaling network helps rationalize the effects of clinically identified HER4 somatic mutations on the cell phenotype.

Authors:  Shannon E Telesco; Rajanikanth Vadigepalli; Ravi Radhakrishnan
Journal:  Biotechnol J       Date:  2013-12-04       Impact factor: 4.677

Review 5.  Computational algorithms for in silico profiling of activating mutations in cancer.

Authors:  E Joseph Jordan; Keshav Patil; Krishna Suresh; Jin H Park; Yael P Mosse; Mark A Lemmon; Ravi Radhakrishnan
Journal:  Cell Mol Life Sci       Date:  2019-04-13       Impact factor: 9.261

6.  Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.

Authors:  Jeonghee Cho; Liang Chen; Naveen Sangji; Takafumi Okabe; Kimio Yonesaka; Joshua M Francis; Richard J Flavin; William Johnson; Jihyun Kwon; Soyoung Yu; Heidi Greulich; Bruce E Johnson; Michael J Eck; Pasi A Jänne; Kwok-Kin Wong; Matthew Meyerson
Journal:  Cancer Res       Date:  2013-09-24       Impact factor: 12.701

7.  Computational study of EGFR inhibition: molecular dynamics studies on the active and inactive protein conformations.

Authors:  Napat Songtawee; M Paul Gleeson; Kiattawee Choowongkomon
Journal:  J Mol Model       Date:  2012-09-07       Impact factor: 1.810

8.  Co-conserved features associated with cis regulation of ErbB tyrosine kinases.

Authors:  Amar Mirza; Morad Mustafa; Eric Talevich; Natarajan Kannan
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

9.  Sequence and structure signatures of cancer mutation hotspots in protein kinases.

Authors:  Anshuman Dixit; Lin Yi; Ragul Gowthaman; Ali Torkamani; Nicholas J Schork; Gennady M Verkhivker
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

10.  Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.

Authors:  Anshuman Dixit; Gennady M Verkhivker
Journal:  PLoS Comput Biol       Date:  2009-08-28       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.